KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Cash from Investing Activities (2016 - 2025)

Chemed (CHE) has 17 years of Cash from Investing Activities data on record, last reported at -$16.0 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 27.4% year-over-year to -$16.0 million; the TTM value through Dec 2025 reached -$59.3 million, up 58.77%, while the annual FY2025 figure was -$59.3 million, 58.77% up from the prior year.
  • Cash from Investing Activities reached -$16.0 million in Q4 2025 per CHE's latest filing, down from -$14.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$10.4 million in Q3 2021 and bottomed at -$93.5 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$19.1 million, with a median of -$15.5 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: plummeted 465.88% in 2024, then skyrocketed 83.44% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$14.0 million in 2021, then tumbled by 38.75% to -$19.5 million in 2022, then surged by 40.12% to -$11.7 million in 2023, then dropped by 7.28% to -$12.5 million in 2024, then dropped by 27.4% to -$16.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$16.0 million in Q4 2025, -$14.2 million in Q3 2025, and -$15.5 million in Q2 2025.